Evidence map›Paper›PMID 32548047›Full record

ArticleIranian journal of public health2020

Immunology, Treatment and Public Health Aspects of Subarachnoid Hemorrhage.

Junjing Zhao, Jianping Zhang, Yongxia Bu, Wei Lu, Gejin Zhao

Open access · goldAbstract read
PubMed Full text at PMC
In one paragraph

Article in Iranian journal of public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Junjing ZhaoMedical Department, Binzhou Central Hospital, Bingzhou 251700, P.R. China.
Jianping ZhangWard 1, Department of Neurology, Gaotang People's Hospital, Gaotang 252800, China.
Yongxia BuCentral Sterile Supply Department, Binzhou People's Hospital, Bingzhou 251700, P.R. China.
Wei LuCerebrovascular and Neurological Severe Cases, Linzi District People's Hospital, Zibo 255400, P.R. China.
Gejin ZhaoDepartment of Neurosurgery for Professional Clinical Medicine, Linzi District People's Hospital, Zibo 255400, P.R. China.
Binzhou People's Hospital · CNLinzi District People's Hospital · CNTang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed to explore the treatment and safety of subarachnoid hemorrhage.

methodsA retrospective analysis was applied on 137 patients with subarachnoid hemorrhage treated in Binzhou Central Hospital, Bingzhou, China from March 2015 to October 2018. Seventy cases with interventional embolization of intracranial aneurysms were divided as the observation group, and 67 cases with craniotomy for aneurysm clipping were divided as the control group. The changes of immune globulins before and after surgery, CD4+, CD8+, NIHSS scores, BI scores, the total effective rate of subarachnoid hemorrhage, the total length of postoperative hospital stay and conditions of postoperative complications as well as 30-day survival were compared between the two groups.

resultsThe levels of Ig G, Ig M, Ig A, and CD4+ after surgery in the observation group were significantly lower than those before surgery (

conclusionPatients with subarachnoid hemorrhage undergoing interventional embolization of aneurysms can reduce the impact on immune function, decrease the adverse reactions caused by treatments, shorten the length of hospital stay and fully improve the efficacy.

Indexed as

Clinical efficacyCraniotomyInterventional embolization of aneurysmsSubarachnoid hemorrhage

Identifiers

PMID32548047
PMCPMC7283182
OpenAlexW3015877921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.